Contacts E. alessio.lodola@unipr.it T. +39 0521 905062 Office: Campus Scienze e Tecnologie - Padiglione 08 - Plesso di Farmacia Address: Parco Area delle Scienze 27/A, 43124 Parma Teacher's social mediaTeacher's activitiesExam scheduleClass schedule Curriculum Vitae Read all Academic Career2002: Laurea in Chimica e Tecnologia Farmaceutiche (Degree in Medicinal and Pharmaceutical Chemistry) at Università di Parma (110/110 cum laude).2006: Dottore in Ricerca in Chimica Farmaceutica (PhD in Medicinal Chemistry) at Università di Pavia.1/11/2005: Ricercatore (Researcher) at the Facoltà di Farmacia (Faculty of Pharmacy), Università di Parma.1/11/2008-30/09/2013: Ricercatore confermato (Researcher) at the Facoltà di Farmacia (Faculty of Pharmacy), Università di Parma.1/10/2014-30/10/2023: Associate Professor of Medicinal Chemistry at the Dipartimento di Farmacia before and after at the Dipartimento di Scienze degli Alimenti e del Farmaco Università di Parma.Since 1/11/2023: Full Professor of Medicinal Chemistry at Dipartimento di Scienze degli Alimenti e del Farmaco Università di Parma.Research experiences outside the Italian UniversityVisiting Scientist (2006, 2007) at the School of Chemistry, University of Bristol (UK), in the computational chemistry group of Prof. Adrian Mulholland (https://mulhollandgroup.wordpress.com).Visiting Scientist (2008) and Scientific Consultant (2010) at the Drug Discovery and Development Department of the Italian Institute of Technology, Genova, led by Prof. Daniele Piomelli.From 2013 to 2016 he has been Visiting Fellow at the "Faculty of Health and Life Sciences" of the Northumbria University, Newcastle, UK.2020: Visiting Professor – School of Chemistry – University of Bristol, Bristol (UK)Other Duties:Since 15/01/2024: Delegate of the Department for the Quality of the ResearchFor the 2021-2023 period is Chair of the Advanced School in Drug Reaseach & Development promoted by Regione Emilia-Romagna Since 2022 Chair of the Board of Teachers of the Master Degree in Pharmaceutical Chemistry and TechnologyMember of the Drug Design and Discovery Group at the Università degli Studi di ParmaMember of the Board of Teachers for the PhD Program in Drug Sciences at Università degli Studi di ParmaChair of the Committee for International Mobility for the Department of Food and Drug of the University of ParmaMember of the Editorial Board of PloS One (http://journals.plos.org/plosone/) Co-Chairman of the First Congress on the Eph/ephrin System, supported by the Italian Division of Medicinal Chemistry of the SCI (Parma, May 2016)Member of the organising committee of the 21st European Symposium on Quantitative Structure-Activity Relationship - EuroQSAR 2016 (Verona, September 2016)Member of the scientific committee of the 12th European Workshop in Drug Design (Certosa di Pontignano, Siena, May 2019)International AwardsRecipient of the New Investigator Award 2009 at the Gordon Rearch Conference on "Cannabinoid Function in the CNS", delivered at the University of New England, Biddeford, (ME), USA, August 2-7, 2009.Runner-up of the EFMC Prize 2010 for a Young Medicinal Chemist in Academia, conferred on occasion of the XXIst International Symposium on Medicinal Chemistry (EFMC-ISMC), held in Brussels on September 5-9, 2010.Plenary speaker at the Gordon Research Conference in Computational Chemistry (Girona, Spain July 2016).Opening lecturer at the conference SBDD2017 - Computational Advances in Drug Discovery (Lausanne, CH, September 2017) Invited speaker at the Pacifichem Conference 2021 - organized by the American and Japanese Chemical Societies (Honolulu, Hawaii, USA, December 2021)Scientific productionThe research activities of Dr. Lodola have led to more than 120 publications in peer-reviewed international journals. Dr. Lodola possesses the following bibliometric indicators of scientific production (Jan 2022, Scopus): H-index = 33; total citations > 3000 Positions President of the single-cycle degree course in PHARMACEUTICAL CHEMISTRY AND TECHNOLOGY Organizational affiliation: Teaching Academic year of provision: 2026/2027 LABORATORY OF DRUG DESIGN Single-cycle degree course 5 years in CHIMICA E TECNOLOGIA FARMACEUTICHE LABORATORY OF DRUG DESIGN - LABORATORY OF DRUG SYNTHESIS module Year: 5° LABORATORY OF DRUG DESIGN Single-cycle degree course 5 years in PHARMACEUTICAL CHEMISTRY AND TECHNOLOGY LABORATORY OF DRUG DESIGN - LABORATORY OF DRUG SYNTHESIS module Year: 5° LABORATORY OF DRUG SYNTHESIS Single-cycle degree course 5 years in CHIMICA E TECNOLOGIA FARMACEUTICHE LABORATORY OF DRUG DESIGN - LABORATORY OF DRUG SYNTHESIS module Year: 5° LABORATORY OF DRUG SYNTHESIS Single-cycle degree course 5 years in PHARMACEUTICAL CHEMISTRY AND TECHNOLOGY LABORATORY OF DRUG DESIGN - LABORATORY OF DRUG SYNTHESIS module Year: 5° Previous years Academic year of provision: 2025/2026 LABORATORY OF DRUG DESIGN Single-cycle degree course 5 years in CHIMICA E TECNOLOGIA FARMACEUTICHE LABORATORY OF DRUG DESIGN - LABORATORY OF DRUG SYNTHESIS module Year: 5° LABORATORY OF DRUG DESIGN Single-cycle degree course 5 years in PHARMACEUTICAL CHEMISTRY AND TECHNOLOGY LABORATORY OF DRUG DESIGN - LABORATORY OF DRUG SYNTHESIS module Year: 5° LABORATORY OF DRUG SYNTHESIS Single-cycle degree course 5 years in CHIMICA E TECNOLOGIA FARMACEUTICHE LABORATORY OF DRUG DESIGN - LABORATORY OF DRUG SYNTHESIS module Year: 5° LABORATORY OF DRUG SYNTHESIS Single-cycle degree course 5 years in PHARMACEUTICAL CHEMISTRY AND TECHNOLOGY LABORATORY OF DRUG DESIGN - LABORATORY OF DRUG SYNTHESIS module Year: 5° Academic year of provision: 2024/2025 Introduction to Scientific Communication Single-cycle degree course 5 years in CHIMICA E TECNOLOGIA FARMACEUTICHE Year: 4° LABORATORY OF DRUG DESIGN Single-cycle degree course 5 years in CHIMICA E TECNOLOGIA FARMACEUTICHE LABORATORY OF DRUG DESIGN - LABORATORY OF DRUG SYNTHESIS module Year: 5° LABORATORY OF DRUG SYNTHESIS Single-cycle degree course 5 years in CHIMICA E TECNOLOGIA FARMACEUTICHE LABORATORY OF DRUG DESIGN - LABORATORY OF DRUG SYNTHESIS module Year: 5° Academic year of provision: 2023/2024 Introduction to Scientific Communication Single-cycle degree course 5 years in CHIMICA E TECNOLOGIA FARMACEUTICHE Year: 4° LABORATORY OF DRUG DESIGN Single-cycle degree course 5 years in CHIMICA E TECNOLOGIA FARMACEUTICHE LABORATORY OF DRUG DESIGN - LABORATORY OF DRUG SYNTHESIS module Year: 5° LABORATORY OF DRUG SYNTHESIS Single-cycle degree course 5 years in CHIMICA E TECNOLOGIA FARMACEUTICHE LABORATORY OF DRUG DESIGN - LABORATORY OF DRUG SYNTHESIS module Year: 5° Academic year of provision: 2022/2023 LABORATORY OF DRUG DESIGN Single-cycle degree course 5 years in CHIMICA E TECNOLOGIA FARMACEUTICHE LABORATORY OF DRUG DESIGN - LABORATORY OF DRUG SYNTHESIS module Year: 5° LABORATORY OF DRUG SYNTHESIS Single-cycle degree course 5 years in CHIMICA E TECNOLOGIA FARMACEUTICHE LABORATORY OF DRUG DESIGN - LABORATORY OF DRUG SYNTHESIS module Year: 5° Academic year of provision: 2021/2022 LABORATORY OF DRUG DESIGN Single-cycle degree course 5 years in Chimica e tecnologia farmaceutiche LABORATORY OF DRUG DESIGN - LABORATORY OF DRUG SYNTHESIS module Year: 5° LABORATORY OF DRUG SYNTHESIS Single-cycle degree course 5 years in Chimica e tecnologia farmaceutiche LABORATORY OF DRUG DESIGN - LABORATORY OF DRUG SYNTHESIS module Year: 5° Academic year of provision: 2020/2021 LABORATORY OF DRUG DESIGN Single-cycle degree course 5 years in Chimica e tecnologia farmaceutiche LABORATORY OF DRUG DESIGN - LABORATORY OF DRUG SYNTHESIS module Year: 5° LABORATORY OF DRUG SYNTHESIS Single-cycle degree course 5 years in Chimica e tecnologia farmaceutiche LABORATORY OF DRUG DESIGN - LABORATORY OF DRUG SYNTHESIS module Year: 5° The teachings are listed up to the 2020/2021 academic year Research Publications The rare bile acid isoallolithocholic acid (IALCA) is an EphA2 antagonist sparing FXR and TGR5 receptors Authors: Blesio Andrea; Giorgio Carmine; Ferrari Francesca Romana; Sala Stefano; Flammini Lisa; Zanotti Ilaria; Passeri Daniela; Gioiello Antimo; Sarcone Lorenzo; Castelli Riccardo; Karnchanapandh Kun; Vacondio Federica; Tagliazucchi Lorenzo; Scalvini Laura; Mor Marco; Lodola Alessio; Tognolini Massimiliano Year: 2026 Spirotetrahydroisoquinoline-Based Histone Deacetylase Inhibitors as New Antifibrotic Agents: Biological Evaluation in Human Fibroblasts from Bronchoalveolar Lavages of Idiopathic Pulmonary Fibrosis Patients Authors: Fontana A.; Bergantini L.; Carullo G.; Scalvini L.; D'Alessandro M.; Papulino C.; Cameli P.; Gangi S.; Vincenzi F.; Varani K.; Contri C.; Pasquini S.; Pistocchi A.; Pezzotta A.; Carbone S.; Saponara S.; Gemma S.; Altucci L.; Benedetti R.; Lodola A.; Mor M.; Bargagli E.; Butini S.; Campiani G. Year: 2025 Reversing TGF-β1-induced fibrotic phenotype in human lung fibroblasts using a PROTAC tool derived from an indoline-based HDAC6 inhibitor Authors: Cursaro I.; Ciccone V.; Tudino V.; Papulino C.; Scalvini L.; Donnini S.; Morbidelli L.; Bini L.; Landi C.; Contri C.; Pasquini S.; Vincenzi F.; Varani K.; Lodola A.; Mor M.; Benedetti R.; Altucci L.; Butini S.; Carullo G.; Gemma S.; Campiani G. Year: 2025 Dual targeting of EphAs and KDR axis hampers VEGF-induced angiogenesis and glioma stem cell replication Authors: Zappia Alfonso; Ferrari Francesca Romana; Giorgio Carmine; Sala Stefano; Zanotti Ilaria; Parrinello Simona; Clements Melanie P.; Rusnati Marco; Corsini Michela; Blesio Andrea; Castelli Riccardo; Guidetti Lorenzo; Scalvini Laura; Lodola Alessio; Tognolini Massimiliano Year: 2025 New Vanillyl-capped HDAC inhibitors exhibit anti-tumor efficacy in neuroblastoma and glioblastoma cells Authors: Cursaro I.; Frattaruolo L.; Scalvini L.; Contri C.; Bichicchi A.; Tardiolo N.; Tudino V.; Rossi S.; Manti E. N.; Cappello M.; Papulino C.; Maellaro E.; Marcolongo P.; Benedetti R.; Altucci L.; Varani K.; Mor M.; Frosini M.; Vincenzi F.; Cappello A. R.; Lodola A.; Saponara S.; Butini S.; Carullo G.; Gemma S.; Campiani G. Year: 2025 Full list of publications Public Engagement Initiatives XXIX National Meeting in Medicinal Chemistry NMMC è il congresso di bandiera della Divisione di Chimica Farmaceutica e rappresenta la migliore opportunità per condividere i progressi nella ricerca e favorire collaborazioni tra ricercatori provenienti sia dal mondo accademico che dall'industria. Gli oltre 350 partecipanti iscritti alla XXIX edizione hanno avuto la possibilità di seguire interventi scientifici tenuti da esperti di livello internazionale che copriranno i più recenti progressi nel campo della chimica farmaceutica, come la modulazione dei segnali lipidici come strategia per realizzare nuovi approcci terapeutici, l’uso dell’intelligenza artificiale e dei metodi computazionali nella progettazione di farmaci, l’utilizzo di tecniche biofisiche per la caratterizzazione dell’interazione tra farmaci e bersagli molecolari e la sostenibilità ambientale. Date: 14/09/2025-17/09/2025 4th congress on the EPh-ephrin system Congresso riguardo il sistema EPh-ephrins Date: 16/05/2024-17/05/2024 Load more initiatives Loading…
Curriculum Vitae Read all Academic Career2002: Laurea in Chimica e Tecnologia Farmaceutiche (Degree in Medicinal and Pharmaceutical Chemistry) at Università di Parma (110/110 cum laude).2006: Dottore in Ricerca in Chimica Farmaceutica (PhD in Medicinal Chemistry) at Università di Pavia.1/11/2005: Ricercatore (Researcher) at the Facoltà di Farmacia (Faculty of Pharmacy), Università di Parma.1/11/2008-30/09/2013: Ricercatore confermato (Researcher) at the Facoltà di Farmacia (Faculty of Pharmacy), Università di Parma.1/10/2014-30/10/2023: Associate Professor of Medicinal Chemistry at the Dipartimento di Farmacia before and after at the Dipartimento di Scienze degli Alimenti e del Farmaco Università di Parma.Since 1/11/2023: Full Professor of Medicinal Chemistry at Dipartimento di Scienze degli Alimenti e del Farmaco Università di Parma.Research experiences outside the Italian UniversityVisiting Scientist (2006, 2007) at the School of Chemistry, University of Bristol (UK), in the computational chemistry group of Prof. Adrian Mulholland (https://mulhollandgroup.wordpress.com).Visiting Scientist (2008) and Scientific Consultant (2010) at the Drug Discovery and Development Department of the Italian Institute of Technology, Genova, led by Prof. Daniele Piomelli.From 2013 to 2016 he has been Visiting Fellow at the "Faculty of Health and Life Sciences" of the Northumbria University, Newcastle, UK.2020: Visiting Professor – School of Chemistry – University of Bristol, Bristol (UK)Other Duties:Since 15/01/2024: Delegate of the Department for the Quality of the ResearchFor the 2021-2023 period is Chair of the Advanced School in Drug Reaseach & Development promoted by Regione Emilia-Romagna Since 2022 Chair of the Board of Teachers of the Master Degree in Pharmaceutical Chemistry and TechnologyMember of the Drug Design and Discovery Group at the Università degli Studi di ParmaMember of the Board of Teachers for the PhD Program in Drug Sciences at Università degli Studi di ParmaChair of the Committee for International Mobility for the Department of Food and Drug of the University of ParmaMember of the Editorial Board of PloS One (http://journals.plos.org/plosone/) Co-Chairman of the First Congress on the Eph/ephrin System, supported by the Italian Division of Medicinal Chemistry of the SCI (Parma, May 2016)Member of the organising committee of the 21st European Symposium on Quantitative Structure-Activity Relationship - EuroQSAR 2016 (Verona, September 2016)Member of the scientific committee of the 12th European Workshop in Drug Design (Certosa di Pontignano, Siena, May 2019)International AwardsRecipient of the New Investigator Award 2009 at the Gordon Rearch Conference on "Cannabinoid Function in the CNS", delivered at the University of New England, Biddeford, (ME), USA, August 2-7, 2009.Runner-up of the EFMC Prize 2010 for a Young Medicinal Chemist in Academia, conferred on occasion of the XXIst International Symposium on Medicinal Chemistry (EFMC-ISMC), held in Brussels on September 5-9, 2010.Plenary speaker at the Gordon Research Conference in Computational Chemistry (Girona, Spain July 2016).Opening lecturer at the conference SBDD2017 - Computational Advances in Drug Discovery (Lausanne, CH, September 2017) Invited speaker at the Pacifichem Conference 2021 - organized by the American and Japanese Chemical Societies (Honolulu, Hawaii, USA, December 2021)Scientific productionThe research activities of Dr. Lodola have led to more than 120 publications in peer-reviewed international journals. Dr. Lodola possesses the following bibliometric indicators of scientific production (Jan 2022, Scopus): H-index = 33; total citations > 3000
Positions President of the single-cycle degree course in PHARMACEUTICAL CHEMISTRY AND TECHNOLOGY Organizational affiliation:
Teaching Academic year of provision: 2026/2027 LABORATORY OF DRUG DESIGN Single-cycle degree course 5 years in CHIMICA E TECNOLOGIA FARMACEUTICHE LABORATORY OF DRUG DESIGN - LABORATORY OF DRUG SYNTHESIS module Year: 5° LABORATORY OF DRUG DESIGN Single-cycle degree course 5 years in PHARMACEUTICAL CHEMISTRY AND TECHNOLOGY LABORATORY OF DRUG DESIGN - LABORATORY OF DRUG SYNTHESIS module Year: 5° LABORATORY OF DRUG SYNTHESIS Single-cycle degree course 5 years in CHIMICA E TECNOLOGIA FARMACEUTICHE LABORATORY OF DRUG DESIGN - LABORATORY OF DRUG SYNTHESIS module Year: 5° LABORATORY OF DRUG SYNTHESIS Single-cycle degree course 5 years in PHARMACEUTICAL CHEMISTRY AND TECHNOLOGY LABORATORY OF DRUG DESIGN - LABORATORY OF DRUG SYNTHESIS module Year: 5° Previous years Academic year of provision: 2025/2026 LABORATORY OF DRUG DESIGN Single-cycle degree course 5 years in CHIMICA E TECNOLOGIA FARMACEUTICHE LABORATORY OF DRUG DESIGN - LABORATORY OF DRUG SYNTHESIS module Year: 5° LABORATORY OF DRUG DESIGN Single-cycle degree course 5 years in PHARMACEUTICAL CHEMISTRY AND TECHNOLOGY LABORATORY OF DRUG DESIGN - LABORATORY OF DRUG SYNTHESIS module Year: 5° LABORATORY OF DRUG SYNTHESIS Single-cycle degree course 5 years in CHIMICA E TECNOLOGIA FARMACEUTICHE LABORATORY OF DRUG DESIGN - LABORATORY OF DRUG SYNTHESIS module Year: 5° LABORATORY OF DRUG SYNTHESIS Single-cycle degree course 5 years in PHARMACEUTICAL CHEMISTRY AND TECHNOLOGY LABORATORY OF DRUG DESIGN - LABORATORY OF DRUG SYNTHESIS module Year: 5° Academic year of provision: 2024/2025 Introduction to Scientific Communication Single-cycle degree course 5 years in CHIMICA E TECNOLOGIA FARMACEUTICHE Year: 4° LABORATORY OF DRUG DESIGN Single-cycle degree course 5 years in CHIMICA E TECNOLOGIA FARMACEUTICHE LABORATORY OF DRUG DESIGN - LABORATORY OF DRUG SYNTHESIS module Year: 5° LABORATORY OF DRUG SYNTHESIS Single-cycle degree course 5 years in CHIMICA E TECNOLOGIA FARMACEUTICHE LABORATORY OF DRUG DESIGN - LABORATORY OF DRUG SYNTHESIS module Year: 5° Academic year of provision: 2023/2024 Introduction to Scientific Communication Single-cycle degree course 5 years in CHIMICA E TECNOLOGIA FARMACEUTICHE Year: 4° LABORATORY OF DRUG DESIGN Single-cycle degree course 5 years in CHIMICA E TECNOLOGIA FARMACEUTICHE LABORATORY OF DRUG DESIGN - LABORATORY OF DRUG SYNTHESIS module Year: 5° LABORATORY OF DRUG SYNTHESIS Single-cycle degree course 5 years in CHIMICA E TECNOLOGIA FARMACEUTICHE LABORATORY OF DRUG DESIGN - LABORATORY OF DRUG SYNTHESIS module Year: 5° Academic year of provision: 2022/2023 LABORATORY OF DRUG DESIGN Single-cycle degree course 5 years in CHIMICA E TECNOLOGIA FARMACEUTICHE LABORATORY OF DRUG DESIGN - LABORATORY OF DRUG SYNTHESIS module Year: 5° LABORATORY OF DRUG SYNTHESIS Single-cycle degree course 5 years in CHIMICA E TECNOLOGIA FARMACEUTICHE LABORATORY OF DRUG DESIGN - LABORATORY OF DRUG SYNTHESIS module Year: 5° Academic year of provision: 2021/2022 LABORATORY OF DRUG DESIGN Single-cycle degree course 5 years in Chimica e tecnologia farmaceutiche LABORATORY OF DRUG DESIGN - LABORATORY OF DRUG SYNTHESIS module Year: 5° LABORATORY OF DRUG SYNTHESIS Single-cycle degree course 5 years in Chimica e tecnologia farmaceutiche LABORATORY OF DRUG DESIGN - LABORATORY OF DRUG SYNTHESIS module Year: 5° Academic year of provision: 2020/2021 LABORATORY OF DRUG DESIGN Single-cycle degree course 5 years in Chimica e tecnologia farmaceutiche LABORATORY OF DRUG DESIGN - LABORATORY OF DRUG SYNTHESIS module Year: 5° LABORATORY OF DRUG SYNTHESIS Single-cycle degree course 5 years in Chimica e tecnologia farmaceutiche LABORATORY OF DRUG DESIGN - LABORATORY OF DRUG SYNTHESIS module Year: 5° The teachings are listed up to the 2020/2021 academic year
Research Publications The rare bile acid isoallolithocholic acid (IALCA) is an EphA2 antagonist sparing FXR and TGR5 receptors Authors: Blesio Andrea; Giorgio Carmine; Ferrari Francesca Romana; Sala Stefano; Flammini Lisa; Zanotti Ilaria; Passeri Daniela; Gioiello Antimo; Sarcone Lorenzo; Castelli Riccardo; Karnchanapandh Kun; Vacondio Federica; Tagliazucchi Lorenzo; Scalvini Laura; Mor Marco; Lodola Alessio; Tognolini Massimiliano Year: 2026 Spirotetrahydroisoquinoline-Based Histone Deacetylase Inhibitors as New Antifibrotic Agents: Biological Evaluation in Human Fibroblasts from Bronchoalveolar Lavages of Idiopathic Pulmonary Fibrosis Patients Authors: Fontana A.; Bergantini L.; Carullo G.; Scalvini L.; D'Alessandro M.; Papulino C.; Cameli P.; Gangi S.; Vincenzi F.; Varani K.; Contri C.; Pasquini S.; Pistocchi A.; Pezzotta A.; Carbone S.; Saponara S.; Gemma S.; Altucci L.; Benedetti R.; Lodola A.; Mor M.; Bargagli E.; Butini S.; Campiani G. Year: 2025 Reversing TGF-β1-induced fibrotic phenotype in human lung fibroblasts using a PROTAC tool derived from an indoline-based HDAC6 inhibitor Authors: Cursaro I.; Ciccone V.; Tudino V.; Papulino C.; Scalvini L.; Donnini S.; Morbidelli L.; Bini L.; Landi C.; Contri C.; Pasquini S.; Vincenzi F.; Varani K.; Lodola A.; Mor M.; Benedetti R.; Altucci L.; Butini S.; Carullo G.; Gemma S.; Campiani G. Year: 2025 Dual targeting of EphAs and KDR axis hampers VEGF-induced angiogenesis and glioma stem cell replication Authors: Zappia Alfonso; Ferrari Francesca Romana; Giorgio Carmine; Sala Stefano; Zanotti Ilaria; Parrinello Simona; Clements Melanie P.; Rusnati Marco; Corsini Michela; Blesio Andrea; Castelli Riccardo; Guidetti Lorenzo; Scalvini Laura; Lodola Alessio; Tognolini Massimiliano Year: 2025 New Vanillyl-capped HDAC inhibitors exhibit anti-tumor efficacy in neuroblastoma and glioblastoma cells Authors: Cursaro I.; Frattaruolo L.; Scalvini L.; Contri C.; Bichicchi A.; Tardiolo N.; Tudino V.; Rossi S.; Manti E. N.; Cappello M.; Papulino C.; Maellaro E.; Marcolongo P.; Benedetti R.; Altucci L.; Varani K.; Mor M.; Frosini M.; Vincenzi F.; Cappello A. R.; Lodola A.; Saponara S.; Butini S.; Carullo G.; Gemma S.; Campiani G. Year: 2025 Full list of publications
Public Engagement Initiatives XXIX National Meeting in Medicinal Chemistry NMMC è il congresso di bandiera della Divisione di Chimica Farmaceutica e rappresenta la migliore opportunità per condividere i progressi nella ricerca e favorire collaborazioni tra ricercatori provenienti sia dal mondo accademico che dall'industria. Gli oltre 350 partecipanti iscritti alla XXIX edizione hanno avuto la possibilità di seguire interventi scientifici tenuti da esperti di livello internazionale che copriranno i più recenti progressi nel campo della chimica farmaceutica, come la modulazione dei segnali lipidici come strategia per realizzare nuovi approcci terapeutici, l’uso dell’intelligenza artificiale e dei metodi computazionali nella progettazione di farmaci, l’utilizzo di tecniche biofisiche per la caratterizzazione dell’interazione tra farmaci e bersagli molecolari e la sostenibilità ambientale. Date: 14/09/2025-17/09/2025 4th congress on the EPh-ephrin system Congresso riguardo il sistema EPh-ephrins Date: 16/05/2024-17/05/2024 Load more initiatives Loading…
